Company · CIK 1826492
Gracell Biotechnologies Inc.
| CIK | 1826492 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-04-23 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-264545 | 2022-04-28 | 2024-02-27 | 3 | |
| 333-274191 | 2023-08-24 | 2024-02-27 | 3 | |
| 333-251494 | 2020-12-18 | 2021-01-08 | 6 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-02-27 | EFFECTDeclared effective | 333-274191 | 9999999995-24-000558 |
| 2024-02-27 | EFFECTDeclared effective | 333-264545 | 9999999995-24-000552 |
| 2023-09-25 | EFFECTDeclared effective | 333-274191 | 9999999995-23-002738 |
| 2023-08-24 | F-3Shelf registered | 333-274191 | 0001104659-23-094883 |
| 2022-06-30 | EFFECTDeclared effective | 333-264545 | 9999999995-22-001936 |
| 2022-04-28 | F-3Shelf registered | 333-264545 | 0001193125-22-127897 |
| 2021-01-08 | 424B4Final prospectus | 333-251494 | 0001193125-21-005025 |
| 2021-01-07 | EFFECTDeclared effective | 333-251864 | 9999999995-21-000086 |
| 2021-01-07 | EFFECTDeclared effective | 333-251494 | 9999999995-21-000069 |
| 2021-01-07 | F-1/AAmendment | 333-251494 | 0001193125-21-003677 |
| 2021-01-06 | F-1/AAmendment | 333-251494 | 0001193125-21-003131 |
| 2021-01-04 | F-1/AAmendment | 333-251494 | 0001193125-21-000413 |
| 2020-12-18 | F-1Registration filed | 333-251494 | 0001193125-20-321500 |
| 2020-10-19 | DRSDraft made public | 377-03682 | 0000950123-20-010314 |